Abstract |
Preclinical Research Baogan Yihao (BGYH) is a traditional Chinese herbal medicine for the treatment of chronic liver diseases. In this study, the effects of BGYH on dimethylnitrosamine (DMN)-induced liver fibrosis were investigated using a rat model. BGYH alleviate liver damage, as indicated by decreased levels of AST, ALT, γ-GT, and AKP. BGYH also prevented collagen deposition and reduced pathological tissue injury in liver tissue. In fibrosis, high levels of α-SMA and TGF-β in liver tissue were markedly attenuated by BGYH. The inhibitory effect of BGYH on HSC-T6 proliferation demonstrated that BGYH exhibited significant hepatoprotective and antifibrogenic effects on DMN-induced liver injury. These findings suggest that BGYH may have therapeutic potential in the prevention and therapy of liver fibrosis. Drug Dev Res 78 : 155-163, 2017. © 2017 Wiley Periodicals, Inc.
|
Authors | Xiujie Liu, Jing Su, Yu Shi, Ying Guo, Imran Suheryani, Shicong Zhao, Yulin Deng, Weiwei Meng, Yan Chen, Lili Sun, Rongji Dai |
Journal | Drug development research
(Drug Dev Res)
Vol. 78
Issue 3-4
Pg. 155-163
(06 2017)
ISSN: 1098-2299 [Electronic] United States |
PMID | 28524372
(Publication Type: Journal Article)
|
Copyright | © 2017 Wiley Periodicals, Inc. |
Chemical References |
- Actins
- Drugs, Chinese Herbal
- Transforming Growth Factor beta
- smooth muscle actin, rat
- Dimethylnitrosamine
|
Topics |
- Actins
(metabolism)
- Animals
- Cell Line
- Chemical and Drug Induced Liver Injury
(metabolism, prevention & control)
- Dimethylnitrosamine
(adverse effects)
- Disease Models, Animal
- Drugs, Chinese Herbal
(administration & dosage, pharmacology)
- Female
- Humans
- Male
- Rats
- Rats, Sprague-Dawley
- Transforming Growth Factor beta
(metabolism)
|